Here’s a comprehensive, SEO-ready breakdown of the Anondita Medicare Limited IPO, covering key aspects and investor essentials.
Anondita Medicare Ltd IPO aims to raise ₹69.50 crore exclusively through a fresh issue. The ₹137–₹145 price band makes the IPO accessible.
Anondita Medicare Ltd, incorporated in March 2024, is a leading player in the sexual wellness sector, especially known for manufacturing male condoms under its flagship brand, “COBRA”.
The company operates multiple production lines at its facility in Noida, Uttar Pradesh, with an annual capacity of ~562 million condoms.
It serves both domestic and international markets, exporting products to Southeast Asia, Africa, and the Middle East.
IPO Dates
| Event | Date |
|---|---|
| IPO Opening Date | August 22, 2025 |
| IPO Closing Date | August 26, 2025 |
| Basis of Allotment Finalization | August 28, 2025 |
| Refunds Initiation | August 29, 2025 |
| Credit of Shares to Demat | August 29, 2025 |
| IPO Listing Date (NSE SME) | September 1, 2025 |
IPO Details
- Face Value: ₹10 per share
- Issue Price Band: ₹137 to ₹145 per share
- Lot Size: 1,000 Shares
- Sale Type: Fresh Capital
- Total Issue Size: 47,93,000 shares
- Issue Type: Bookbuilding IPO
- Listing At: NSE SME
- Share Holding Pre Issue: 1,32,93,618 shares
- Share Holding Post Issue: 1,80,86,618 shares
GMP of Anondita Medicare Limited IPO
As of now, the Grey Market Premium (GMP) for the Anondita Medicare Limited IPO is not available. No active GMP is reported at this time.
| Parameter | Status |
|---|---|
| GMP (Grey Market Premium) | Not available / Not started |
| Kostak Rate | Not available |
| Subject to Sauda Rate | Not available |
Promoters of Anondita Medicare Limited
Here are the promoter details for Anondita Medicare Limited, as per the latest publicly available information:
- Mr. Anupam Ghosh
- Mrs. Sonia Ghosh
- Mr. Reshant Ghosh
Promoter Background & Roles
Based on company filings and corporate records:
| Promoter | Role(s) & Affiliation |
|---|---|
| Anupam Ghosh | Managing Director – overseeing corporate strategy and operations in Anondita Medicare Ltd. Appointed on March 12, 2024. |
| Sonia Ghosh | Whole-Time Director – involved in daily operations and execution. Appointed on March 12, 2024. |
| Reshant Ghosh | Whole-Time Director – plays an executive role in business functions. Appointed on March 12, 2024. |
These founders bring operational continuity from their previous enterprise, M/s Anondita Healthcare, dating back to 1999 before restructuring into the present corporate entity.
Corporate Experience: Anupam Ghosh
Mr. Anupam Ghosh holds significant leadership experience across multiple Anondita group businesses:
Managing Director, Anondita Medicare Limited (since March 12, 2024)
Other directorships include:
- Anondita Exultia Healthcare Pvt. Ltd. (Director since April 2016)
- Suncity Healthcare Pvt. Ltd. (Director since May 2023)
- Latex Products (India) Pvt. Ltd. (Director since March 2014)
- Healthcare Products Pvt. Ltd. (Director since December 2014)
- Healthcare Pvt. Ltd. (Director since August 2009)
- All India Condom Manufacturer Association (Director since December 2021)
These roles indicate a deep-rooted involvement in the company’s operations and industry domain.
Anondita Medicare Limited IPO Lot Size
Here’s the detailed lot size information for the Anondita Medicare Limited IPO, meticulously organized into a clear and informative table based on verified sources:
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 2 | 2,000 | ₹2,90,000 |
| Retail (Max) | 2 | 2,000 | ₹2,90,000 |
| S-HNI (Min) | 3 | 3,000 | ₹4,35,000 |
| S-HNI (Max) | 6 | 6,000 | ₹8,70,000 |
| B-HNI (Min) | 7 | 7,000 | ₹10,15,000 |
Key Highlights
- Lot Size: 1,000 shares per lot is the basic trading unit.
- Retail Investors: May apply for a minimum of 1 lot (₹145,000) and a maximum of 2 lots (₹290,000).
- SHNI investors can apply for 3 to 6 lots.
- BHNI investors have a minimum lot requirement of 7 lots.
Anondita Medicare Limited IPO Promoter Holding
Here’s the detailed breakdown of the promoter shareholding in the Anondita Medicare Limited IPO, based on reliable sources:
| Category | Shareholding (%) |
|---|---|
| Pre-IPO Promoter Holding | 83.95% |
| Post-IPO Promoter Holding | 61.71% |
The promoters—Mr. Anupam Ghosh, Mrs. Sonia Ghosh, and Mr. Reshant Ghosh—collectively held 83.95% of the company’s equity before the IPO. Following the offering, their combined stake is expected to dilute to around 61.71%.
About Anondita Medicare Limited
Founded in March 2024, Anondita Medicare Limited (formerly Anondita Healthcare) is headquartered in Noida, Uttar Pradesh. Its Corporate Identification Number (CIN) is U22193DL2024PLC428183.
Manufacturing Facility & Capacity:
- Operates a state-of-the-art manufacturing plant in Noida.
- Annual production capacity: ~562 million condoms, supported by 11 production lines.
- The company also runs units for surgical and household gloves in Mathura and 3-ply/5-ply masks production facilities.
Product Portfolio:
- Offers a diverse range under its signature brand “COBRA”, including electronically tested flavored male condoms (e.g., strawberry, mint, chocolate, bubblegum).
Market Reach & Collaborations:
- Exports products to Southeast Asia, Africa, and the Middle East.
- Collaborates with government health programs, NGOs, and health organizations for family planning and public health initiatives.
Anondita Medicare Limited Financial Information
Here is a comprehensive and updated financial overview of Anondita Medicare Limited, presented with clarity and precision through a structured table format:
| Period Ended | 31 Mar 2025 | Mar 31 2024 | 31 Mar 2023 |
| Assets | ₹78.27 Crore | ₹42.92 Crore | 37.80 Crore |
| Total Income | ₹77.13 Crore | ₹46.56 Crore | ₹36.14 Crore |
| Profit After Tax | ₹16.42 Crore | ₹3.84 Crore | ₹0.35 Crore |
| EBITDA | ₹25.65 Crore | ₹9.09 Crore | ₹3.58 Crore |
| Net Worth | ₹37.87 Crore | ₹10.59 Crore | ₹8.69 Crore |
| Reserves and Surplus | ₹24.58 Crore | ₹10.39 Crore | ₹6.55 Crore |
| Total Borrowing | ₹27.39 Crore | ₹24.01 Crore | ₹22.66 Crore |
Key Performance Indicator (KPI)
Here are the Key Performance Indicators (KPIs) for Anondita Medicare Limited IPO, derived from its financials and IPO disclosures:
| KPI | Values |
|---|---|
| ROE | 41.71% |
| ROCE | 37.42% |
| Debt/Equity | 0.70 |
| RoNW | 41.71% |
| PAT Margin | 21.32% |
| EBITDA Margin | 33.32% |
| Price to Book Value | 15.07 |
Strengths of Anondita Medicare Limited IPO
Established Flagship Brand – “COBRA”
Anondita Medicare’s flagship product “COBRA” is a well-recognized brand in the sexual wellness market, giving it strong brand equity and consumer recall.
Robust Production Infrastructure
The company boasts an annual manufacturing capacity of approximately 562 million condoms, supported by 11 modern production lines and embedded quality control systems.
Operational Efficiency & High Margins
Reported EBITDA margin stands at 33%, with ROE around 42% and ROCE near 37%, indicating strong profitability and effective capital employment.
Growth-Oriented Financial Performance
Revenue growth from ₹35.91 Cr (FY23) to ₹60.52 Cr (FY25), with PAT rising from ₹0.35 Cr to ₹10.80 Cr, shows a steep upward trend in both sales and earnings.
Diverse Market Access
Anondita has a strong distribution footprint across domestic retail, exports to Southeast Asia, Africa, and the Middle East, and partnerships with NGOs and government health programs.
Credible Leadership with Industry Experience
The promoters, led by Mr. Anupam Ghosh, bring decades of experience in the sexual wellness industry, lending credibility and strategic depth to the business.
Risks of Anondita Medicare Limited IPO
Product Concentration Risk
The company’s revenues rely heavily on condom sales—particularly the male segment—exposing it to demand fluctuations in a single product category.
Regulatory & Tender Dependency
With a significant portion of business tied to government tenders and health programs, the IPO faces risk from policy changes or lower tender volumes.
Foreign Exchange Fluctuations
Export exposure subjects the company’s earnings to currency volatility, which could impact profit margins if not hedged properly.
Customer Concentration
The business may depend heavily on a few large enterprise or institutional buyers, increasing vulnerability to contract risks.
Stringent Regulatory Compliance
Operating in healthcare and sexual wellness demands adherence to strict manufacturing and safety standards—non-compliance could result in operational or reputational harm.
Anondita Medicare Limited Contact Details
Here are the SEO-optimized, full contact details for Anondita Medicare Limited IPO.
Anondita Medicare Limited — Contact Details
Corporate Office
- Address: D-001, Sector 80, Gautam Budh Nagar, Noida, Uttar Pradesh 201305, India
- Phone: +91-120-4520300 (Landline), +91-7678182056 (Mobile)
- Email: info@anonditamedicare.com (official correspondence) / info@anonditahealthcare.com
- Website: www.anonditamedicare.com
Registrar & Lead Manager (for IPO-related queries)
Registrar – Maashitla Securities Pvt. Ltd.
- Address: 451, Krishna Apra Business Square, Pitampura, Delhi 110034
- Phone: +91-11-45121795
- Email: ipo@maashitla.com
Lead Manager – Narnolia Financial Services Ltd.
- Address: 201, 2nd Floor, Marble Arch, 236B A.J.C. Bose Road, Kolkata, West Bengal 700020
- Phone: +91-81306 78743 / 033-40501500
- Email: [typically available on their site
Quick Reference Table
| Contact Point | Details |
|---|---|
| Corporate Address | D-001, Sector 80, Noida, Uttar Pradesh 201305, India |
| Phone | +91-120-4520300 (Landline), +91-7678182056 (Mobile) |
| info@anonditamedicare.com / info@anonditahealthcare.com | |
| Website | www.anonditamedicare.com |
| IPO Registrar | Maashitla Securities — +91-11-45121795; ipo@maashitla.com |
| IPO Lead Manager | Narnolia Financial Services — +91-81306 78743; 033-40501500 |
Shivashrit Foods Limited IPO 2025: Price, Lot Size & Review
Classic Electrodes (India) Limited IPO: Date, Price & Review
Disclaimer: The content on this website is intended for informational purposes only and should not be interpreted as financial or investment advice. Engaging in stock market activities involves inherent risks, and outcomes can be unpredictable. While we strive to provide accurate and up-to-date information, we do not make any guarantees regarding the completeness or reliability of the content. Any investment decisions you make should be based on your own research and consultation with a qualified financial professional. We are not responsible for any financial gains or losses resulting from actions taken based on the information provided here. Always invest wisely and at your own risk.
